Surgical Strategies in the Treatment of MR-negative Cushing's Disease: a Systematic Review and Treatment Algorithm

Overview

Journal Pituitary

Specialty Endocrinology

Date 2022 Jun 17

PMID 35710682

Authors

Andrew B Yang

Fraser Henderson Jr

Theodore H Schwartz

Affiliations

Soon will be listed here.

Abstract

Purpose: Several surgical strategies have been proposed to treat MRI-negative Cushing's Disease. These include tumor removal, if identified, and if a tumor is not identified, resection of varying degrees of the pituitary gland, often guided by inferior petrosal sinus sampling (IPSS). The relative risks and benefits of each strategy have never been compared.

Methods: This systematic review of the literature included only studies on the results of surgery for MRI-negative patients with Cushing's Disease in which the surgical strategy was clearly described and associated remission and/or hypopituitarism rates detailed for each strategy.

Results: We identified 12 studies that met inclusion criteria for remission rates and 5 studies for hypopituitarism rates. We divided cases into 6 resection strategies. Remission and hypopituitarism rates for each strategy were: (1) tumor identified, resect tumor only (68%, 0%); (2) resect tumor and surrounding capsule (85%, 0%); and if the tumor was not identified (3) resect inferior 1/3 of gland (78%, no data); (4) resect 30-50% of gland based on IPSS (68%, 13%); (5) resect > 50% but < 100% of gland (65%, 9%); (6) resect entire gland (66%, 67%). Strategy 3 only contained 9 patients.

Conclusion: Remission rates for MRI-negative Cushing's Disease support surgery as a reasonable approach. Results are best if a tumor is found. If a tumor is not identified, one can either remove one-third of the gland guided by IPSS lateralization, or remove both lateral portions along with the inferior portion leaving sufficient central gland to preserve function. Our recommendations are limited by the lack of rigorous and objective data.

Citing Articles

Double pituitary adenomas: report of two cases and systematic review of the literature.

Zhang Y, Gong X, Pu J, Liu J, Ye Z, Zhu H Front Endocrinol (Lausanne). 2024; 15:1373869.

PMID: 38628582 PMC: 11018951. DOI: 10.3389/fendo.2024.1373869.

Pediatric pituitary neuroendocrine tumors-a 13-year experience in a tertiary center.

Li X, Deng K, Zhang Y, Feng M, Xing B, Lian W Front Oncol. 2023; 13:1270958.

PMID: 38023185 PMC: 10661939. DOI: 10.3389/fonc.2023.1270958.

An individualized approach to the management of Cushing disease.

Fleseriu M, Varlamov E, Hinojosa-Amaya J, Langlois F, Melmed S Nat Rev Endocrinol. 2023; 19(10):581-599.

PMID: 37537306 DOI: 10.1038/s41574-023-00868-7.

References

PLOTZ C, KNOWLTON A, RAGAN C . The natural history of Cushing's syndrome. Am J Med. 1952; 13(5):597-614. DOI: 10.1016/0002-9343(52)90027-2. View

Aranda G, Ensenat J, Mora M, Puig-Domingo M, Martinez de Osaba M, Casals G . Long-term remission and recurrence rate in a cohort of Cushing's disease: the need for long-term follow-up. Pituitary. 2014; 18(1):142-9. DOI: 10.1007/s11102-014-0567-8. View

Carr S, Kleinschmidt-DeMasters B, Kerr J, Kiseljak-Vassiliades K, Wierman M, Lillehei K . Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature. J Neurosurg. 2017; 129(5):1260-1267. DOI: 10.3171/2017.5.JNS162901. View

Lonser R, Wind J, Nieman L, Weil R, DeVroom H, Oldfield E . Outcome of surgical treatment of 200 children with Cushing's disease. J Clin Endocrinol Metab. 2013; 98(3):892-901. PMC: 3590477. DOI: 10.1210/jc.2012-3604. View

Oldfield E, Vortmeyer A . Development of a histological pseudocapsule and its use as a surgical capsule in the excision of pituitary tumors. J Neurosurg. 2006; 104(1):7-19. DOI: 10.3171/jns.2006.104.1.7. View

Salenave S, Gatta B, Pecheur S, San-Galli F, Visot A, Lasjaunias P . Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocorticotropin-secreting microadenomas. J Clin Endocrinol Metab. 2004; 89(7):3371-6. DOI: 10.1210/jc.2003-031908. View

Tritos N, Biller B, Swearingen B . Management of Cushing disease. Nat Rev Endocrinol. 2011; 7(5):279-89. DOI: 10.1038/nrendo.2011.12. View

Cebula H, Baussart B, Villa C, Assie G, Boulin A, Foubert L . Efficacy of endoscopic endonasal transsphenoidal surgery for Cushing's disease in 230 patients with positive and negative MRI. Acta Neurochir (Wien). 2017; 159(7):1227-1236. DOI: 10.1007/s00701-017-3140-1. View

Andereggen L, Mariani L, Beck J, Andres R, Gralla J, Luedi M . Lateral one-third gland resection in Cushing patients with failed adenoma identification leads to low remission rates: long-term observations from a small, single-center cohort. Acta Neurochir (Wien). 2021; 163(11):3161-3169. PMC: 8520517. DOI: 10.1007/s00701-021-04830-2. View

10.

Hammer G, Tyrrell J, Lamborn K, Applebury C, Hannegan E, Bell S . Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. J Clin Endocrinol Metab. 2004; 89(12):6348-57. DOI: 10.1210/jc.2003-032180. View

11.

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

12.

Pouratian N, Prevedello D, Jagannathan J, Lopes M, Vance M, Laws Jr E . Outcomes and management of patients with Cushing's disease without pathological confirmation of tumor resection after transsphenoidal surgery. J Clin Endocrinol Metab. 2007; 92(9):3383-8. DOI: 10.1210/jc.2007-0208. View

13.

Watson J, Shawker T, Nieman L, DeVroom H, Doppman J, Oldfield E . Localization of pituitary adenomas by using intraoperative ultrasound in patients with Cushing's disease and no demonstrable pituitary tumor on magnetic resonance imaging. J Neurosurg. 1998; 89(6):927-32. DOI: 10.3171/jns.1998.89.6.0927. View

14.

Yamada S, Fukuhara N, Nishioka H, Takeshita A, Inoshita N, Ito J . Surgical management and outcomes in patients with Cushing disease with negative pituitary magnetic resonance imaging. World Neurosurg. 2011; 77(3-4):525-32. DOI: 10.1016/j.wneu.2011.06.033. View

15.

Jagannathan J, Sheehan J, Jane Jr J . Evaluation and management of Cushing syndrome in cases of negative sellar magnetic resonance imaging. Neurosurg Focus. 2007; 23(3):E3. DOI: 10.3171/foc.2007.23.3.4. View

16.

Hinojosa-Amaya J, Cuevas-Ramos D . The definition of remission and recurrence of Cushing's disease. Best Pract Res Clin Endocrinol Metab. 2021; 35(1):101485. DOI: 10.1016/j.beem.2021.101485. View

17.

Invitti C, Pecori Giraldi F, De Martin M, Cavagnini F . Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab. 1999; 84(2):440-8. DOI: 10.1210/jcem.84.2.5465. View

18.

Mampalam T, Tyrrell J, Wilson C . Transsphenoidal microsurgery for Cushing disease. A report of 216 cases. Ann Intern Med. 1988; 109(6):487-93. DOI: 10.7326/0003-4819-109-6-487. View

19.

Sonino N, Zielezny M, Fava G, Fallo F, Boscaro M . Risk factors and long-term outcome in pituitary-dependent Cushing's disease. J Clin Endocrinol Metab. 1996; 81(7):2647-52. DOI: 10.1210/jcem.81.7.8675592. View

20.

Bigos S, Somma M, Rasio E, Eastman R, Lanthier A, Johnston H . Cushing's disease: management by transsphenoidal pituitary microsurgery. J Clin Endocrinol Metab. 1980; 50(2):348-54. DOI: 10.1210/jcem-50-2-348. View